COVID-19感染后手术时机与乳腺癌术后血栓 并发症风险分析.
- Published in:
- China Oncology, 2023, v. 33, n. 10, p. 920, doi. 10.19401/j.cnki.1007-3639.2023.10.004
- By:
- Publication type:
- Article
Works matching IS 10073639 AND DT 2023 AND VI 33 AND IP 10
Results: 8
1
2
FBW7基因通过GSDME介导的焦亡增强紫杉 醇对胰腺癌的抗肿瘤作用研究.
- Published in:
- China Oncology, 2023, v. 33, n. 10, p. 889, doi. 10.19401/j.cnki.1007-3639.2023.10.001
- By:
- Publication type:
- Article
3
CDK4/6抑制剂不良反应评估：基于FAERS数 据库的真实世界研究.
- Published in:
- China Oncology, 2023, v. 33, n. 10, p. 908, doi. 10.19401/j.cnki.1007-3639.2023.10.003
- By:
- Publication type:
- Article
4
去势抵抗性前列腺癌免疫微环境的研究现状与 治疗方向.
- Published in:
- China Oncology, 2023, v. 33, n. 10, p. 945, doi. 10.19401/j.cnki.1007-3639.2023.10.007
- By:
- Publication type:
- Article
5
身体剂量参数对局部晚期鼻咽癌患者免疫细胞 减少的影响分析：一项回顾性队列研究.
- Published in:
- China Oncology, 2023, v. 33, n. 10, p. 898, doi. 10.19401/j.cnki.1007-3639.2023.10.002
- By:
- Publication type:
- Article
6
恶性肿瘤患者血流感染病原分析及血糖检测的 临床意义.
- Published in:
- China Oncology, 2023, v. 33, n. 10, p. 927, doi. 10.19401/j.cnki.1007-3639.2023.10.005
- By:
- Publication type:
- Article
7
妇科恶性肿瘤免疫治疗中国专家共识（2023 年版）.
- Published in:
- China Oncology, 2023, v. 33, n. 10, p. 954, doi. 10.19401/j.cnki.1007-3639.2023.10.008
- By:
- Publication type:
- Article
8
NRAS 突变型晚期黑色素瘤的治疗进展.
- Published in:
- China Oncology, 2023, v. 33, n. 10, p. 936, doi. 10.19401/j.cnki.1007-3639.2023.10.006
- By:
- Publication type:
- Article